Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Histone Modifications WP2369,0.008159175764881071,5.475473321858864,26.329427401846445,"['SETD2', 'AEBP2', 'H3F3B', 'EHMT1', 'SMYD3']",0.9995759620548411,0,0,5
2,Biotin Metabolism (including IEMs) WP5031,0.012984737637624649,11.475225225225225,49.84815620776183,"['PCCA', 'HLCS', 'ACACA']",0.9995759620548411,0,0,3
3,Nanomaterial-induced inflammasome activation WP3890,0.013443884882587335,inf,inf,"['NFKB1', 'CTSB']",0.9995759620548411,0,0,2
4,Autophagy WP4923,0.030388326337574666,4.373791621911923,15.280701558778837,"['PRKAB2', 'ATG9A', 'WIPI2', 'ATG7']",0.9995759620548411,0,0,4
5,Cell Differentiation - Index WP2029,0.03722035852476443,15.280359820089956,50.286126890842276,"['LEFTY1', 'MEF2D']",0.9995759620548411,0,0,2
6,Mitochondrial fatty acid synthesis pathway WP4317,0.03722035852476443,15.280359820089956,50.286126890842276,"['MCAT', 'ACACA']",0.9995759620548411,0,0,2
7,Folate Metabolism WP176,0.041502918291277564,3.8263157894736843,12.175304448309515,"['GPX3', 'SHMT2', 'INSR', 'NFKB1']",0.9995759620548411,0,0,4
8,Mesodermal commitment pathway WP2857,0.054793340268862546,2.030614973262032,5.897284836437582,"['MBTD1', 'PPP2CA', 'CCDC88A', 'SETD2', 'LEFTY1', 'CTBP2', 'AEBP2', 'NABP2', 'ACACA']",0.9995759620548411,0,0,9
9,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.06875734175946267,7.638680659670165,20.4500601373893,"['AEBP2', 'STK38']",0.9995759620548411,0,0,2
10,Vitamin B12 metabolism WP1533,0.07654107014053166,3.8220720720720722,9.822449338996211,"['SHMT2', 'INSR', 'NFKB1']",0.9995759620548411,0,0,3
11,p53 transcriptional gene network WP4963,0.10539113260715145,2.5488721804511276,5.735158101477963,"['PRKAB2', 'TIGAR', 'SIVA1', 'ZMAT3']",0.9995759620548411,0,0,4
12,Nanoparticle triggered autophagic cell death WP2509,0.10593911740551208,5.091454272863568,11.429758417801443,"['INSR', 'ATG7']",0.9995759620548411,0,0,2
13,Serine Metabolism WP4688,0.11602471730305895,inf,inf,['SHMT2'],0.9995759620548411,0,0,1
14,Autosomal recessive Osteopetrosis pathways WP4788,0.11602471730305895,inf,inf,['NFKB1'],0.9995759620548411,0,0,1
15,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.11602471730305895,inf,inf,['TOB1'],0.9995759620548411,0,0,1
16,Complement Activation WP545,0.11602471730305895,inf,inf,['C2'],0.9995759620548411,0,0,1
17,Disorders of Folate Metabolism and Transport WP4259,0.11602471730305895,inf,inf,['SHMT2'],0.9995759620548411,0,0,1
18,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.11602471730305895,inf,inf,['SIX4'],0.9995759620548411,0,0,1
19,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.11602471730305895,inf,inf,['NKRF'],0.9995759620548411,0,0,1
20,DNA IR-double strand breaks and cellular response via ATM WP3959,0.11954640863290356,2.1247489959839356,4.513074435524277,"['CDK5', 'ABL1', 'NABP2', 'MCPH1', 'STK3']",0.9995759620548411,0,0,5
21,Energy Metabolism WP1541,0.12643126640996383,2.8654279279279278,5.925866757130228,"['PRKAB2', 'NRF1', 'MEF2D']",0.9995759620548411,0,0,3
22,Oxidative Stress WP408,0.12643126640996383,2.8654279279279278,5.925866757130228,"['GPX3', 'NFKB1', 'TXN2']",0.9995759620548411,0,0,3
23,16p11.2 proximal deletion syndrome WP4949,0.14252578822309578,1.8360180995475113,3.5769898120350945,"['PPP2CA', 'DOC2A', 'IGFBP3', 'MAZ', 'NFKB1', 'BPTF']",0.9995759620548411,0,0,6
24,Cell Differentiation - Index expanded WP2023,0.1470352898999922,3.81784107946027,7.319116907894661,"['LEFTY1', 'MEF2D']",0.9995759620548411,0,0,2
25,HIF1A and PPARG regulation of glycolysis WP2456,0.1470352898999922,3.81784107946027,7.319116907894661,"['LDHA', 'GPAT3']",0.9995759620548411,0,0,2
26,Rett syndrome causing genes WP4312,0.15474072785311438,2.5465465465465464,4.751866770749683,"['SRRM3', 'FOXG1', 'HDAC8']",0.9995759620548411,0,0,3
27,Modulators of TCR signaling and T cell activation WP5072,0.17097081019542718,2.037894736842105,3.599456925593341,"['RNF7', 'MEF2D', 'NFKB1', 'ZFP36L1']",0.9995759620548411,0,0,4
28,Neural Crest Differentiation WP2064,0.17097081019542718,2.037894736842105,3.599456925593341,"['CTBP2', 'HDAC8', 'NFKB1', 'CDH7']",0.9995759620548411,0,0,4
29,Vitamin D-sensitive calcium signaling in depression WP4698,0.18478005326863023,2.2914414414414415,3.8693029552815084,"['CALB1', 'ITPR2', 'ATP2B3']",0.9995759620548411,0,0,3
30,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.18478005326863023,2.2914414414414415,3.8693029552815084,"['WIPI2', 'ATG7', 'ACACA']",0.9995759620548411,0,0,3
31,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.18478005326863023,2.2914414414414415,3.8693029552815084,"['ATF1', 'ITPR2', 'ATF4']",0.9995759620548411,0,0,3
32,Sphingolipid Metabolism (general overview) WP4725,0.1906400515015555,3.0536731634182908,5.061060721079466,"['SMPD1', 'CERS1']",0.9995759620548411,0,0,2
33,Sphingolipid Metabolism (integrated pathway) WP4726,0.1906400515015555,3.0536731634182908,5.061060721079466,"['SMPD1', 'CERS1']",0.9995759620548411,0,0,2
34,Type II diabetes mellitus WP1584,0.1906400515015555,3.0536731634182908,5.061060721079466,"['KCNJ11', 'INSR']",0.9995759620548411,0,0,2
35,NRF2-ARE regulation WP4357,0.1906400515015555,3.0536731634182908,5.061060721079466,"['AIMP2', 'INSR']",0.9995759620548411,0,0,2
36,Interferon type I signaling pathways WP585,0.21617127831360045,2.0827190827190827,3.190067975281608,"['IFNAR2', 'GAB2', 'CRKL']",0.9995759620548411,0,0,3
37,Photodynamic therapy-induced unfolded protein response WP3613,0.21617127831360045,2.0827190827190827,3.190067975281608,"['DDIT3', 'DNAJB9', 'ATF4']",0.9995759620548411,0,0,3
38,Alanine and aspartate metabolism WP106,0.21860557955779752,7.62874251497006,11.599397561077458,['GOT2'],0.9995759620548411,0,0,1
39,Tgif disruption of Shh signaling WP3674,0.21860557955779752,7.62874251497006,11.599397561077458,['FOXG1'],0.9995759620548411,0,0,1
40,Caloric restriction and aging WP4191,0.21860557955779752,7.62874251497006,11.599397561077458,['PRKAB2'],0.9995759620548411,0,0,1
41,Disorders of the Krebs cycle WP4236,0.21860557955779752,7.62874251497006,11.599397561077458,['DHTKD1'],0.9995759620548411,0,0,1
42,Glial Cell Differentiation WP2276,0.21860557955779752,7.62874251497006,11.599397561077458,['TPPP'],0.9995759620548411,0,0,1
43,Riboflavin and CoQ disorders WP5037,0.21860557955779752,7.62874251497006,11.599397561077458,['PDSS2'],0.9995759620548411,0,0,1
44,Prolactin Signaling Pathway WP2037,0.2188502075197558,1.6612100576217914,2.5239890159618175,"['TEC', 'AGAP2', 'GAB2', 'CTSD', 'NFKB1']",0.9995759620548411,0,0,5
45,Hippo-Yap signaling pathway WP4537,0.23562032428001217,2.5442278860569716,3.677766806002125,"['NF2', 'STK3']",0.9995759620548411,0,0,2
46,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.23562032428001217,2.5442278860569716,3.677766806002125,"['STAG1', 'MAD1L1']",0.9995759620548411,0,0,2
47,B Cell Receptor Signaling Pathway WP23,0.26410821768861437,1.527710843373494,2.0339886320776466,"['TEC', 'GAB2', 'MEF2D', 'NFKB1', 'CRKL']",0.9995759620548411,0,0,5
48,Ciliary landscape WP4352,0.27709749741627066,1.2743161094224924,1.6354392740812143,"['MYL6', 'CTBP2', 'GDI1', 'SSNA1', 'VPS4A', 'EXOC6B', 'HTRA2', 'YPEL5', 'EXOC2', 'NFKB1', 'ARL8B']",0.9995759620548411,0,0,11
49,1q21.1 copy number variation syndrome WP4905,0.28107154018232466,2.180338402227458,2.7671678722786464,"['PRKAB2', 'ACP6']",0.9995759620548411,0,0,2
50,Gastric Cancer Network 1 WP2361,0.28107154018232466,2.180338402227458,2.7671678722786464,"['RNF216', 'CEP192']",0.9995759620548411,0,0,2
51,Monoamine Transport WP727,0.28107154018232466,2.180338402227458,2.7671678722786464,"['SYN1', 'STX1A']",0.9995759620548411,0,0,2
52,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.28159151285468237,1.7616077616077617,2.2324816304655832,"['TEC', 'GAB2', 'NFKB1']",0.9995759620548411,0,0,3
53,Endoderm differentiation WP2853,0.2955640743557788,1.3887289181406828,1.6926795053320565,"['MBTD1', 'CTBP2', 'AEBP2', 'NABP2', 'ACACA', 'BPTF']",0.9995759620548411,0,0,6
54,Metabolic reprogramming in colon cancer WP4290,0.3011241776630326,1.5269172932330828,1.8326558348673954,"['LDHA', 'TIGAR', 'SHMT2', 'GOT2']",0.9995759620548411,0,0,4
55,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.30929818697484157,3.813622754491018,4.475093565763073,['NFKB1'],0.9995759620548411,0,0,1
56,Supression of HMGB1 mediated inflammation by THBD WP4479,0.30929818697484157,3.813622754491018,4.475093565763073,['NFKB1'],0.9995759620548411,0,0,1
57,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.30929818697484157,3.813622754491018,4.475093565763073,['NFKB1'],0.9995759620548411,0,0,1
58,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.30929818697484157,3.813622754491018,4.475093565763073,['ATG7'],0.9995759620548411,0,0,1
59,Insulin signaling in adipocytes (diabetic condition) WP3635,0.30929818697484157,3.813622754491018,4.475093565763073,['INSR'],0.9995759620548411,0,0,1
60,Insulin signaling in adipocytes (normal condition) WP3634,0.30929818697484157,3.813622754491018,4.475093565763073,['INSR'],0.9995759620548411,0,0,1
61,LTF danger signal response pathway WP4478,0.30929818697484157,3.813622754491018,4.475093565763073,['NFKB1'],0.9995759620548411,0,0,1
62,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.30929818697484157,3.813622754491018,4.475093565763073,['ADK'],0.9995759620548411,0,0,1
63,Molybdenum cofactor (Moco) biosynthesis WP4507,0.30929818697484157,3.813622754491018,4.475093565763073,['GPHN'],0.9995759620548411,0,0,1
64,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.30929818697484157,3.813622754491018,4.475093565763073,['TNKS'],0.9995759620548411,0,0,1
65,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.30929818697484157,3.813622754491018,4.475093565763073,['NFKB1'],0.9995759620548411,0,0,1
66,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.32627998852539325,1.9074212893553224,2.1363107105313124,"['PPP2CA', 'RBL1']",0.9995759620548411,0,0,2
67,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.32627998852539325,1.9074212893553224,2.1363107105313124,"['LDHA', 'ACACA']",0.9995759620548411,0,0,2
68,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.32627998852539325,1.9074212893553224,2.1363107105313124,"['IFNAR2', 'NFKB1']",0.9995759620548411,0,0,2
69,Imatinib and Chronic Myeloid Leukemia WP3640,0.32627998852539325,1.9074212893553224,2.1363107105313124,"['ABL1', 'GAB2']",0.9995759620548411,0,0,2
70,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.32627998852539325,1.9074212893553224,2.1363107105313124,"['NF2', 'STK3']",0.9995759620548411,0,0,2
71,Integrated breast cancer pathway WP1984,0.3383234691143312,1.3088558500323206,1.4184762340560726,"['ATF1', 'GDI1', 'ABL1', 'JAKMIP1', 'NFKB1', 'DHTKD1']",0.9995759620548411,0,0,6
72,Ciliopathies WP4803,0.3396817728763175,1.2468430640032109,1.3462738880232321,"['DYNC2H1', 'KIAA0556', 'AHI1', 'ARL2BP', 'SCLT1', 'NEK1', 'KIZ', 'SDCCAG8']",0.9995759620548411,0,0,8
73,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3593391971525883,1.242815991006815,1.2720078715630323,"['PPP2CA', 'MARCKS', 'DOCK3', 'CDK5', 'MAP2K5', 'NFKB1', 'SYN1']",0.9995759620548411,0,0,7
74,Kit receptor signaling pathway WP304,0.3817006868221534,1.4304617117117118,1.3777041664940295,"['TEC', 'GAB2', 'CRKL']",0.9995759620548411,0,0,3
75,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3817006868221534,1.4304617117117118,1.3777041664940295,"['LDHA', 'IGFBP3', 'HIF1AN']",0.9995759620548411,0,0,3
76,Proteasome Degradation WP183,0.38408587418653894,1.326969597907813,1.2697627717401805,"['PSMD10', 'PSMC5', 'PSMB5', 'PSME3']",0.9995759620548411,0,0,4
77,Serotonin Transporter Activity WP1455,0.38947844795944914,2.5419161676646707,2.396891583438673,['STX1A'],0.9995759620548411,0,0,1
78,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.38947844795944914,2.5419161676646707,2.396891583438673,['MEF2D'],0.9995759620548411,0,0,1
79,Aspirin and miRNAs WP4707,0.38947844795944914,2.5419161676646707,2.396891583438673,['NFKB1'],0.9995759620548411,0,0,1
80,Cancer immunotherapy by CTLA4 blockade WP4582,0.38947844795944914,2.5419161676646707,2.396891583438673,['PPP2CA'],0.9995759620548411,0,0,1
81,Canonical NF-KB pathway WP4562,0.38947844795944914,2.5419161676646707,2.396891583438673,['NFKB1'],0.9995759620548411,0,0,1
82,Transcription co-factors SKI and SKIL protein partners WP4533,0.38947844795944914,2.5419161676646707,2.396891583438673,['STK3'],0.9995759620548411,0,0,1
83,Transcription factor regulation in adipogenesis WP3599,0.38947844795944914,2.5419161676646707,2.396891583438673,['INSR'],0.9995759620548411,0,0,1
84,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.38947844795944914,2.5419161676646707,2.396891583438673,['NFKB1'],0.9995759620548411,0,0,1
85,FOXA2 pathway WP5066,0.38947844795944914,2.5419161676646707,2.396891583438673,['ACACA'],0.9995759620548411,0,0,1
86,Glutathione metabolism WP100,0.38947844795944914,2.5419161676646707,2.396891583438673,['GPX3'],0.9995759620548411,0,0,1
87,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.38947844795944914,2.5419161676646707,2.396891583438673,['NFKB1'],0.9995759620548411,0,0,1
88,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.38947844795944914,2.5419161676646707,2.396891583438673,['NFKB1'],0.9995759620548411,0,0,1
89,Leptin and adiponectin WP3934,0.38947844795944914,2.5419161676646707,2.396891583438673,['ACACA'],0.9995759620548411,0,0,1
90,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.38947844795944914,2.5419161676646707,2.396891583438673,['HIF1AN'],0.9995759620548411,0,0,1
91,Mitochondrial Gene Expression WP391,0.38947844795944914,2.5419161676646707,2.396891583438673,['NRF1'],0.9995759620548411,0,0,1
92,"NAD metabolism, sirtuins and aging WP3630",0.38947844795944914,2.5419161676646707,2.396891583438673,['NFKB1'],0.9995759620548411,0,0,1
93,NAD+ metabolism WP3644,0.38947844795944914,2.5419161676646707,2.396891583438673,['NMNAT3'],0.9995759620548411,0,0,1
94,Osteoclast Signaling WP12,0.38947844795944914,2.5419161676646707,2.396891583438673,['AIMP2'],0.9995759620548411,0,0,1
95,Ectoderm Differentiation WP2858,0.40341831695074876,1.204810669206954,1.0937045329814437,"['TRPM2', 'AHI1', 'BCAS3', 'NF2', 'JAKMIP1', 'ANKS1B']",0.9995759620548411,0,0,6
96,Pathways Regulating Hippo Signaling WP4540,0.40766991439533967,1.2305674310143802,1.1041850368121726,"['PRKAB2', 'INSR', 'NF2', 'CDH7', 'STK3']",0.9995759620548411,0,0,5
97,16p11.2 distal deletion syndrome WP4950,0.41388080774234803,1.5253373313343328,1.345617893214086,"['INSR', 'SDCCAG8']",0.9995759620548411,0,0,2
98,Unfolded protein response WP4925,0.41388080774234803,1.5253373313343328,1.345617893214086,"['DDIT3', 'ATF4']",0.9995759620548411,0,0,2
99,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.414578759611548,1.3460519342872284,1.185188378792188,"['ABL1', 'RNF7', 'NFKB1']",0.9995759620548411,0,0,3
100,Glycogen Synthesis and Degradation WP500,0.414578759611548,1.3460519342872284,1.185188378792188,"['PPP2CA', 'PPP2R2B', 'PPP2R5B']",0.9995759620548411,0,0,3
101,mRNA Processing WP411,0.43168046636308366,1.1918768825301205,1.0012595664908992,"['PRPF4', 'NUDT21', 'LSM7', 'HNRNPK', 'PSKH1']",0.9995759620548411,0,0,5
102,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.44687574068661157,1.271021021021021,1.0237752858383053,"['DDIT3', 'PPP1R9B', 'ATF4']",0.9995759620548411,0,0,3
103,Splicing factor NOVA regulated synaptic proteins WP4148,0.45553547360094204,1.3863977102357912,1.0900991303698027,"['KCNMA1', 'GPHN']",0.9995759620548411,0,0,2
104,ATM Signaling Pathway WP2516,0.45553547360094204,1.3863977102357912,1.0900991303698027,"['CRADD', 'ABL1']",0.9995759620548411,0,0,2
105,Target Of Rapamycin (TOR) Signaling WP1471,0.45553547360094204,1.3863977102357912,1.0900991303698027,"['PRKAB2', 'RRAGC']",0.9995759620548411,0,0,2
106,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.45553547360094204,1.3863977102357912,1.0900991303698027,"['HDAC8', 'NFKB1']",0.9995759620548411,0,0,2
107,Lipid Metabolism Pathway WP3965,0.45553547360094204,1.3863977102357912,1.0900991303698027,"['PRKAB2', 'ACACA']",0.9995759620548411,0,0,2
108,Netrin-UNC5B signaling pathway WP4747,0.45553547360094204,1.3863977102357912,1.0900991303698027,"['AGAP2', 'PLEKHH1']",0.9995759620548411,0,0,2
109,One-carbon metabolism and related pathways WP3940,0.45553547360094204,1.3863977102357912,1.0900991303698027,"['GPX3', 'SHMT2']",0.9995759620548411,0,0,2
110,Parkinson's disease pathway WP2371,0.45553547360094204,1.3863977102357912,1.0900991303698027,"['PRKN', 'HTRA2']",0.9995759620548411,0,0,2
111,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.46036325053251853,1.906062874251497,1.4786081201015862,['NFKB1'],0.9995759620548411,0,0,1
112,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.46036325053251853,1.906062874251497,1.4786081201015862,['IFNAR2'],0.9995759620548411,0,0,1
113,Vitamin D in inflammatory diseases WP4482,0.46036325053251853,1.906062874251497,1.4786081201015862,['NFKB1'],0.9995759620548411,0,0,1
114,ID signaling pathway WP53,0.46036325053251853,1.906062874251497,1.4786081201015862,['RBL1'],0.9995759620548411,0,0,1
115,Osteopontin Signaling WP1434,0.46036325053251853,1.906062874251497,1.4786081201015862,['NFKB1'],0.9995759620548411,0,0,1
116,Phytochemical activity on NRF2 transcriptional activation WP3,0.46036325053251853,1.906062874251497,1.4786081201015862,['AIMP2'],0.9995759620548411,0,0,1
117,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.46036325053251853,1.906062874251497,1.4786081201015862,['LDHA'],0.9995759620548411,0,0,1
118,SARS coronavirus and innate immunity WP4912,0.46036325053251853,1.906062874251497,1.4786081201015862,['IFNAR2'],0.9995759620548411,0,0,1
119,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.4954294868494279,1.2706146926536732,0.8923911250928168,"['TNFSF12', 'NFKB1']",0.9995759620548411,0,0,2
120,IL-2 signaling pathway WP49,0.4954294868494279,1.2706146926536732,0.8923911250928168,"['GAB2', 'CRKL']",0.9995759620548411,0,0,2
121,EGF/EGFR signaling pathway WP437,0.497555199398384,1.0673413897280968,0.7450563495785206,"['ATF1', 'PLSCR1', 'ABL1', 'GAB2', 'MEF2D', 'MAP2K5', 'CRKL']",0.9995759620548411,0,0,7
122,Ras signaling WP4223,0.497555199398384,1.0673413897280968,0.7450563495785206,"['INSR', 'GNB2', 'ABL1', 'KSR2', 'GAB2', 'NFKB1', 'EXOC2']",0.9995759620548411,0,0,7
123,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.5021650764223596,1.0890705679862307,0.7501805323918,"['PRKAB2', 'INSR', 'FLOT1', 'MAPK6', 'MAP2K5']",0.9995759620548411,0,0,5
124,Genes related to primary cilium development (based on CRISPR) WP4536,0.5091234821360926,1.1434684684684684,0.7719151921503807,"['DYNC2H1', 'SCLT1', 'CEP192']",0.9995759620548411,0,0,3
125,Leptin signaling pathway WP2034,0.5091234821360926,1.1434684684684684,0.7719151921503807,"['PDE3B', 'ACACA', 'NFKB1']",0.9995759620548411,0,0,3
126,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.5230288075380022,1.524550898203593,0.9880899997385543,['NRF1'],0.9995759620548411,0,0,1
127,Airway smooth muscle cell contraction WP4962,0.5230288075380022,1.524550898203593,0.9880899997385543,['GDI1'],0.9995759620548411,0,0,1
128,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5230288075380022,1.524550898203593,0.9880899997385543,['NFKB1'],0.9995759620548411,0,0,1
129,Cancer immunotherapy by PD-1 blockade WP4585,0.5230288075380022,1.524550898203593,0.9880899997385543,['NFKB1'],0.9995759620548411,0,0,1
130,Cellular Proteostasis WP4918,0.5230288075380022,1.524550898203593,0.9880899997385543,['PFDN2'],0.9995759620548411,0,0,1
131,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5230288075380022,1.524550898203593,0.9880899997385543,['MYRIP'],0.9995759620548411,0,0,1
132,Dopamine metabolism WP2436,0.5230288075380022,1.524550898203593,0.9880899997385543,['PPP2CA'],0.9995759620548411,0,0,1
133,Gastric Cancer Network 2 WP2363,0.5230288075380022,1.524550898203593,0.9880899997385543,['BRIX1'],0.9995759620548411,0,0,1
134,IL1 and megakaryocytes in obesity WP2865,0.5230288075380022,1.524550898203593,0.9880899997385543,['NFKB1'],0.9995759620548411,0,0,1
135,Immune response to tuberculosis WP4197,0.5230288075380022,1.524550898203593,0.9880899997385543,['IFNAR2'],0.9995759620548411,0,0,1
136,Leptin Insulin Overlap WP3935,0.5230288075380022,1.524550898203593,0.9880899997385543,['INSR'],0.9995759620548411,0,0,1
137,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5230288075380022,1.524550898203593,0.9880899997385543,['NFKB1'],0.9995759620548411,0,0,1
138,miRNAs involvement in the immune response in sepsis WP4329,0.5230288075380022,1.524550898203593,0.9880899997385543,['NFKB1'],0.9995759620548411,0,0,1
139,MTHFR deficiency WP4288,0.5230288075380022,1.524550898203593,0.9880899997385543,['EHMT1'],0.9995759620548411,0,0,1
140,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.5230288075380022,1.524550898203593,0.9880899997385543,['NFKB1'],0.9995759620548411,0,0,1
141,Overview of interferons-mediated signaling pathway WP4558,0.5230288075380022,1.524550898203593,0.9880899997385543,['IFNAR2'],0.9995759620548411,0,0,1
142,Pregnane X receptor pathway WP2876,0.5230288075380022,1.524550898203593,0.9880899997385543,['PSMC5'],0.9995759620548411,0,0,1
143,Nephrotic syndrome WP4758,0.5334103183065583,1.1726444470072657,0.7369651985252252,"['PDSS2', 'SYNPO']",0.9995759620548411,0,0,2
144,Oxidative Damage WP3941,0.5334103183065583,1.1726444470072657,0.7369651985252252,"['NFKB1', 'C2']",0.9995759620548411,0,0,2
145,p38 MAPK Signaling Pathway WP400,0.5334103183065583,1.1726444470072657,0.7369651985252252,"['DDIT3', 'MEF2D']",0.9995759620548411,0,0,2
146,MECP2 and Associated Rett Syndrome WP3584,0.5388376518755785,1.0888030888030888,0.6732515427183473,"['MPP1', 'GRID1', 'FOXG1']",0.9995759620548411,0,0,3
147,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.567493321659275,1.039107289107289,0.5886816054080228,"['HNRNPK', 'CTBP2', 'CXXC4']",0.9995759620548411,0,0,3
148,Hippo-Merlin Signaling Dysregulation WP4541,0.5677943413782808,1.0159398496240601,0.5750178920058122,"['INSR', 'NF2', 'CDH7', 'STK3']",0.9995759620548411,0,0,4
149,Regulation of toll-like receptor signaling pathway WP1449,0.5677943413782808,1.0159398496240601,0.5750178920058122,"['IFNAR2', 'FBXW5', 'RNF216', 'NFKB1']",0.9995759620548411,0,0,4
150,ATM Signaling Network in Development and Disease  WP3878,0.5693844100529555,1.0886699507389161,0.6131383546308754,"['CDK5', 'NFKB1']",0.9995759620548411,0,0,2
151,TGF-beta Receptor Signaling WP560,0.5693844100529555,1.0886699507389161,0.6131383546308754,"['LEFTY1', 'NFKB1']",0.9995759620548411,0,0,2
152,Vitamin A and carotenoid metabolism WP716,0.5693844100529555,1.0886699507389161,0.6131383546308754,"['RBP4', 'BCO2']",0.9995759620548411,0,0,2
153,Regulation of Microtubule Cytoskeleton WP2038,0.5693844100529555,1.0886699507389161,0.6131383546308754,"['ABL1', 'TPPP']",0.9995759620548411,0,0,2
154,TLR4 Signaling and Tolerance WP3851,0.5784268953202878,1.2702095808383234,0.6953674829077202,['NFKB1'],0.9995759620548411,0,0,1
155,Transcriptional cascade regulating adipogenesis WP4211,0.5784268953202878,1.2702095808383234,0.6953674829077202,['DDIT3'],0.9995759620548411,0,0,1
156,Tryptophan catabolism leading to NAD+ production WP4210,0.5784268953202878,1.2702095808383234,0.6953674829077202,['NMNAT3'],0.9995759620548411,0,0,1
157,Tumor suppressor activity of SMARCB1 WP4204,0.5784268953202878,1.2702095808383234,0.6953674829077202,['H3F3B'],0.9995759620548411,0,0,1
158,Glycerophospholipid Biosynthetic Pathway WP2533,0.5784268953202878,1.2702095808383234,0.6953674829077202,['GPAT3'],0.9995759620548411,0,0,1
159,miRNAs involved in DNA damage response WP1545,0.5784268953202878,1.2702095808383234,0.6953674829077202,['ABL1'],0.9995759620548411,0,0,1
160,NAD+ biosynthetic pathways WP3645,0.5784268953202878,1.2702095808383234,0.6953674829077202,['TNKS'],0.9995759620548411,0,0,1
161,Nicotine Activity on Dopaminergic Neurons WP1602,0.5784268953202878,1.2702095808383234,0.6953674829077202,['CDK5'],0.9995759620548411,0,0,1
162,RalA downstream regulated genes WP2290,0.5784268953202878,1.2702095808383234,0.6953674829077202,['EXOC2'],0.9995759620548411,0,0,1
163,RAS and bradykinin pathways in COVID-19 WP4969,0.5784268953202878,1.2702095808383234,0.6953674829077202,['NFKB1'],0.9995759620548411,0,0,1
164,MAPK Signaling Pathway WP382,0.5933322752059442,0.9638693071589097,0.5031404604927773,"['CACNB1', 'DDIT3', 'CACNA2D3', 'CACNA1D', 'MAP2K5', 'NFKB1', 'CRKL', 'ATF4', 'DUSP7', 'STK3']",0.9995759620548411,0,0,10
165,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5950274422188307,0.9937328632980806,0.5158941831865576,"['PRKAB2', 'RBP4', 'ACACA']",0.9995759620548411,0,0,3
166,T-cell receptor (TCR) signaling pathway WP69,0.5950274422188307,0.9937328632980806,0.5158941831865576,"['GAB2', 'NFKB1', 'CRKL']",0.9995759620548411,0,0,3
167,AGE/RAGE pathway WP2324,0.6033055776763233,1.0158920539730134,0.5133622029506272,"['INSR', 'NFKB1']",0.9995759620548411,0,0,2
168,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6033055776763233,1.0158920539730134,0.5133622029506272,"['IFNAR2', 'NFKB1']",0.9995759620548411,0,0,2
169,Cell cycle WP179,0.6108595639399362,0.9519954819277109,0.4692273323377992,"['ANAPC13', 'STAG1', 'RBL1', 'ABL1', 'MAD1L1']",0.9995759620548411,0,0,5
170,TNF-alpha signaling pathway WP231,0.6145579374960188,0.9520676691729323,0.46351611595131903,"['PPP2CA', 'KSR2', 'RFFL', 'NFKB1']",0.9995759620548411,0,0,4
171,Amino Acid metabolism WP3925,0.6213951183411841,0.9521396396396397,0.4530167462202985,"['LDHA', 'AUH', 'GOT2']",0.9995759620548411,0,0,3
172,Sphingolipid pathway WP1422,0.6273992224014231,1.0885372112917022,0.5074458111976112,['PPP2CA'],0.9995759620548411,0,0,1
173,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6273992224014231,1.0885372112917022,0.5074458111976112,['NFKB1'],0.9995759620548411,0,0,1
174,Trans-sulfuration and one-carbon metabolism WP2525,0.6273992224014231,1.0885372112917022,0.5074458111976112,['SHMT2'],0.9995759620548411,0,0,1
175,Zinc homeostasis WP3529,0.6273992224014231,1.0885372112917022,0.5074458111976112,['SLC39A7'],0.9995759620548411,0,0,1
176,Ebstein-Barr virus LMP1 signaling WP262,0.6273992224014231,1.0885372112917022,0.5074458111976112,['NFKB1'],0.9995759620548411,0,0,1
177,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6273992224014231,1.0885372112917022,0.5074458111976112,['H3F3B'],0.9995759620548411,0,0,1
178,GABA receptor Signaling WP4159,0.6273992224014231,1.0885372112917022,0.5074458111976112,['GPHN'],0.9995759620548411,0,0,1
179,Glycolysis in senescence WP5049,0.6273992224014231,1.0885372112917022,0.5074458111976112,['LDHA'],0.9995759620548411,0,0,1
180,One-carbon metabolism WP241,0.6273992224014231,1.0885372112917022,0.5074458111976112,['SHMT2'],0.9995759620548411,0,0,1
181,Ovarian infertility WP34,0.6273992224014231,1.0885372112917022,0.5074458111976112,['SMPD1'],0.9995759620548411,0,0,1
182,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.6273992224014231,1.0885372112917022,0.5074458111976112,['NFKB1'],0.9995759620548411,0,0,1
183,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6351653042748817,0.9522113943028486,0.43218017817595417,"['LEFTY1', 'NFKB1']",0.9995759620548411,0,0,2
184,RANKL/RANK signaling pathway WP2018,0.6351653042748817,0.9522113943028486,0.43218017817595417,"['GAB2', 'NFKB1']",0.9995759620548411,0,0,2
185,Myometrial relaxation and contraction pathways WP289,0.6416651050975241,0.9186634024377539,0.4076006208742043,"['ATF1', 'GRK4', 'IGFBP3', 'GNB2', 'ITPR2', 'NFKB1', 'ATF4']",0.9995759620548411,0,0,7
186,Selenium Micronutrient Network WP15,0.6465674945980369,0.9138738738738739,0.39852000441816826,"['GPX3', 'INSR', 'NFKB1']",0.9995759620548411,0,0,3
187,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6465674945980369,0.9138738738738739,0.39852000441816826,"['CACNB1', 'CACNA2D3', 'CACNA1D']",0.9995759620548411,0,0,3
188,Wnt signaling pathway and pluripotency WP399,0.6465674945980369,0.9138738738738739,0.39852000441816826,"['PPP2CA', 'CTBP2', 'PPP2R2B']",0.9995759620548411,0,0,3
189,3q29 copy number variation syndrome WP4906,0.6649846436928619,0.8960225769468207,0.36556944358112914,"['DYNC2H1', 'NF2']",0.9995759620548411,0,0,2
190,IL-3 signaling pathway WP286,0.6649846436928619,0.8960225769468207,0.36556944358112914,"['GAB2', 'CRKL']",0.9995759620548411,0,0,2
191,AMP-activated protein kinase (AMPK) signaling WP1403,0.670529742670067,0.8785516285516286,0.35114585655140945,"['PRKAB2', 'INSR', 'ACACA']",0.9995759620548411,0,0,3
192,Translation Factors WP107,0.670529742670067,0.8785516285516286,0.35114585655140945,"['EIF5A', 'EIF2B3', 'EIF3I']",0.9995759620548411,0,0,3
193,Apoptosis Modulation by HSP70 WP384,0.6706901411369036,0.9522829341317365,0.3803875471343297,['NFKB1'],0.9995759620548411,0,0,1
194,Toll-like Receptor Signaling related to MyD88 WP3858,0.6706901411369036,0.9522829341317365,0.3803875471343297,['NFKB1'],0.9995759620548411,0,0,1
195,TP53 network WP1742,0.6706901411369036,0.9522829341317365,0.3803875471343297,['ABL1'],0.9995759620548411,0,0,1
196,Cori Cycle WP1946,0.6706901411369036,0.9522829341317365,0.3803875471343297,['LDHA'],0.9995759620548411,0,0,1
197,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6706901411369036,0.9522829341317365,0.3803875471343297,['NFKB1'],0.9995759620548411,0,0,1
198,Intraflagellar transport proteins binding to dynein WP4532,0.6706901411369036,0.9522829341317365,0.3803875471343297,['DYNC2H1'],0.9995759620548411,0,0,1
199,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6706901411369036,0.9522829341317365,0.3803875471343297,['GOT2'],0.9995759620548411,0,0,1
200,Proteoglycan biosynthesis WP4784,0.6706901411369036,0.9522829341317365,0.3803875471343297,['CANT1'],0.9995759620548411,0,0,1
201,SARS-CoV-2 mitochondrial interactions WP5038,0.6706901411369036,0.9522829341317365,0.3803875471343297,['NFKB1'],0.9995759620548411,0,0,1
202,Retinoblastoma gene in cancer WP2446,0.6932791722068684,0.8458458458458459,0.30985237756566314,"['FAF1', 'PRIM1', 'ABL1']",0.9995759620548411,0,0,3
203,Ebola Virus Pathway on Host WP4217,0.6981043118089717,0.8456140350877193,0.30390247435596673,"['VPS4A', 'VPS11', 'NFKB1', 'CTSB']",0.9995759620548411,0,0,4
204,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.7089578932914923,0.846307385229541,0.2910951630084889,['ATF1'],0.9995759620548411,0,0,1
205,Cardiac Progenitor Differentiation WP2406,0.7089578932914923,0.846307385229541,0.2910951630084889,['MESP1'],0.9995759620548411,0,0,1
206,Computational Model of Aerobic Glycolysis WP4629,0.7089578932914923,0.846307385229541,0.2910951630084889,['LDHA'],0.9995759620548411,0,0,1
207,Ethanol effects on histone modifications WP3996,0.7089578932914923,0.846307385229541,0.2910951630084889,['HDAC8'],0.9995759620548411,0,0,1
208,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7089578932914923,0.846307385229541,0.2910951630084889,['NFKB1'],0.9995759620548411,0,0,1
209,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7089578932914923,0.846307385229541,0.2910951630084889,['ZMAT3'],0.9995759620548411,0,0,1
210,Nanomaterial induced apoptosis WP2507,0.7089578932914923,0.846307385229541,0.2910951630084889,['HTRA2'],0.9995759620548411,0,0,1
211,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.7089578932914923,0.846307385229541,0.2910951630084889,['EIF3I'],0.9995759620548411,0,0,1
212,22q11.2 copy number variation syndrome WP4657,0.7148234779933396,0.8154761904761905,0.2737713818162519,"['PRKN', 'THAP7', 'CRKL']",0.9995759620548411,0,0,3
213,Male infertility WP4673,0.7148234779933396,0.8154761904761905,0.2737713818162519,"['PACRG', 'ABLIM1', 'INSR']",0.9995759620548411,0,0,3
214,Chemokine signaling pathway WP3929,0.716826829718755,0.8225970331233489,0.27385981713208424,"['GRK4', 'GNB2', 'NFKB1', 'CRKL']",0.9995759620548411,0,0,4
215,Genotoxicity pathway WP4286,0.7186950149910243,0.8013887792945632,0.2647132916070099,"['PRKAB2', 'TIGAR']",0.9995759620548411,0,0,2
216,IL-4 signaling pathway WP395,0.7186950149910243,0.8013887792945632,0.2647132916070099,"['GAB2', 'NFKB1']",0.9995759620548411,0,0,2
217,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7186950149910243,0.8013887792945632,0.2647132916070099,"['CTBP2', 'CXXC4']",0.9995759620548411,0,0,2
218,Pathogenic Escherichia coli infection WP2272,0.7186950149910243,0.8013887792945632,0.2647132916070099,"['ABL1', 'ARPC4']",0.9995759620548411,0,0,2
219,Vitamin D Receptor Pathway WP2877,0.7346809926848573,0.800791452314998,0.2468991377394613,"['CDC34', 'SATB1', 'IGFBP3', 'CLEC16A']",0.9995759620548411,0,0,4
220,Corticotropin-releasing hormone signaling pathway WP2355,0.735179129933181,0.7872009940975458,0.24217537602020875,"['GNB2', 'ACACA', 'NFKB1']",0.9995759620548411,0,0,3
221,"GPCRs, Other WP117",0.7427210666533618,0.7611694152923538,0.22639821172160698,"['GPR83', 'SSTR2']",0.9995759620548411,0,0,2
222,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7427210666533618,0.7611694152923538,0.22639821172160698,"['IFNAR2', 'MAPK6']",0.9995759620548411,0,0,2
223,Signal Transduction of S1P Receptor WP26,0.7427845586706859,0.7615269461077845,0.22643945693111775,['MAPK6'],0.9995759620548411,0,0,1
224,Signal transduction through IL1R WP4496,0.7427845586706859,0.7615269461077845,0.22643945693111775,['NFKB1'],0.9995759620548411,0,0,1
225,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7427845586706859,0.7615269461077845,0.22643945693111775,['CRKL'],0.9995759620548411,0,0,1
226,Urea cycle and associated pathways WP4595,0.7427845586706859,0.7615269461077845,0.22643945693111775,['GOT2'],0.9995759620548411,0,0,1
227,White fat cell differentiation WP4149,0.7427845586706859,0.7615269461077845,0.22643945693111775,['DDIT3'],0.9995759620548411,0,0,1
228,Fatty Acid Biosynthesis WP357,0.7427845586706859,0.7615269461077845,0.22643945693111775,['ACACA'],0.9995759620548411,0,0,1
229,Melatonin metabolism and effects WP3298,0.7427845586706859,0.7615269461077845,0.22643945693111775,['NFKB1'],0.9995759620548411,0,0,1
230,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7427845586706859,0.7615269461077845,0.22643945693111775,['STK3'],0.9995759620548411,0,0,1
231,Prion disease pathway WP3995,0.7427845586706859,0.7615269461077845,0.22643945693111775,['NFKB1'],0.9995759620548411,0,0,1
232,Pathways in clear cell renal cell carcinoma WP4018,0.7516747409648664,0.7801041064198959,0.22268194499201588,"['SETD2', 'LDHA', 'SHMT2', 'ACACA']",0.9995759620548411,0,0,4
233,Toll-like Receptor Signaling Pathway WP75,0.7649684252372356,0.7247804669094025,0.1941837046864027,"['IFNAR2', 'NFKB1']",0.9995759620548411,0,0,2
234,Joubert Syndrome WP4656,0.7649684252372356,0.7247804669094025,0.1941837046864027,"['AHI1', 'ATF4']",0.9995759620548411,0,0,2
235,Complement and Coagulation Cascades WP558,0.7726848557244688,0.6921611322808927,0.17849728379090077,['C2'],0.9995759620548411,0,0,1
236,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7726848557244688,0.6921611322808927,0.17849728379090077,['NFKB1'],0.9995759620548411,0,0,1
237,Fatty acid beta-oxidation WP143,0.7726848557244688,0.6921611322808927,0.17849728379090077,['CRAT'],0.9995759620548411,0,0,1
238,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7726848557244688,0.6921611322808927,0.17849728379090077,['H3F3B'],0.9995759620548411,0,0,1
239,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7726848557244688,0.6921611322808927,0.17849728379090077,['DDIT3'],0.9995759620548411,0,0,1
240,IL17 signaling pathway WP2112,0.7726848557244688,0.6921611322808927,0.17849728379090077,['NFKB1'],0.9995759620548411,0,0,1
241,Integrated Cancer Pathway WP1971,0.7726848557244688,0.6921611322808927,0.17849728379090077,['ATF1'],0.9995759620548411,0,0,1
242,Pre-implantation embryo WP3527,0.7726848557244688,0.6921611322808927,0.17849728379090077,['DDIT3'],0.9995759620548411,0,0,1
243,Resistin as a regulator of inflammation WP4481,0.7726848557244688,0.6921611322808927,0.17849728379090077,['NFKB1'],0.9995759620548411,0,0,1
244,Calcium Regulation in the Cardiac Cell WP536,0.7814248784868802,0.7727586471355166,0.19059030146674424,"['CACNB1', 'GRK4', 'GNB2', 'ITPR2', 'ATP2B3', 'CACNA1D']",0.9995759620548411,0,0,6
245,Cardiac Hypertrophic Response WP2795,0.7855257373954183,0.691699604743083,0.16697770685915048,"['MAP2K5', 'NFKB1']",0.9995759620548411,0,0,2
246,DNA damage response WP707,0.7855257373954183,0.691699604743083,0.16697770685915048,"['CDK5', 'ABL1']",0.9995759620548411,0,0,2
247,DNA IR-damage and cellular response via ATR WP4016,0.7855257373954183,0.691699604743083,0.16697770685915048,"['PALB2', 'MCPH1']",0.9995759620548411,0,0,2
248,Glycolysis and Gluconeogenesis WP534,0.7855257373954183,0.691699604743083,0.16697770685915048,"['LDHA', 'GOT2']",0.9995759620548411,0,0,2
249,Alzheimer's disease WP2059,0.7893807340636756,0.7129786036036037,0.16862408969064258,"['CDK5', 'ITPR2', 'CACNA1D']",0.9995759620548411,0,0,3
250,BDNF-TrkB Signaling WP3676,0.7991139265371254,0.6343562874251497,0.14225551200381487,['GAB2'],0.9995759620548411,0,0,1
251,Notch Signaling WP268,0.7991139265371254,0.6343562874251497,0.14225551200381487,['CTBP2'],0.9995759620548411,0,0,1
252,Oxidation by Cytochrome P450 WP43,0.7991139265371254,0.6343562874251497,0.14225551200381487,['CYP3A43'],0.9995759620548411,0,0,1
253,Synaptic Vesicle Pathway WP2267,0.804485046647986,0.6614953392868783,0.1439102293056105,"['SYN1', 'STX1A']",0.9995759620548411,0,0,2
254,miRNA regulation of DNA damage response WP1530,0.804485046647986,0.6614953392868783,0.1439102293056105,"['CDK5', 'ABL1']",0.9995759620548411,0,0,2
255,Apoptosis Modulation and Signaling WP1772,0.8052736906211325,0.6912366912366913,0.14970325300713086,"['CRADD', 'HTRA2', 'NFKB1']",0.9995759620548411,0,0,3
256,DNA damage response (only ATM dependent) WP710,0.8052736906211325,0.6912366912366913,0.14970325300713086,"['INSR', 'ABL1', 'NFKB1']",0.9995759620548411,0,0,3
257,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8052736906211325,0.6912366912366913,0.14970325300713086,"['PRKN', 'PSMD10', 'PSMC5']",0.9995759620548411,0,0,3
258,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8085459148099496,0.7761880165289257,0.16495377855423193,"['PPP2CA', 'IFNAR2', 'TBC1D1', 'PPP2R2B', 'INSR', 'GNB2', 'PPP2R5B', 'ACACA', 'ATF4']",0.9995759620548411,0,0,9
259,Senescence and Autophagy in Cancer WP615,0.8201456186946463,0.670773714891362,0.13299656543921104,"['RSL1D1', 'IGFBP3', 'ATG7']",0.9995759620548411,0,0,3
260,Allograft Rejection WP2328,0.8224742234299227,0.5854444956241364,0.1144181810315429,['C2'],0.9995759620548411,0,0,1
261,Estrogen signaling pathway WP712,0.8224742234299227,0.5854444956241364,0.1144181810315429,['NFKB1'],0.9995759620548411,0,0,1
262,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.8224742234299227,0.5854444956241364,0.1144181810315429,['LRSAM1'],0.9995759620548411,0,0,1
263,Neovascularisation processes WP4331,0.8224742234299227,0.5854444956241364,0.1144181810315429,['NFKB1'],0.9995759620548411,0,0,1
264,Metapathway biotransformation Phase I and II WP702,0.8242817168993808,0.6907723855092276,0.13348687149282953,"['CHST12', 'GPX3', 'CYP3A43', 'NAA80']",0.9995759620548411,0,0,4
265,Development of ureteric collection system WP5053,0.8431216004774484,0.5435201026518391,0.09274849009539188,['FREM1'],0.9995759620548411,0,0,1
266,Differentiation Pathway WP2848,0.8431216004774484,0.5435201026518391,0.09274849009539188,['LEFTY1'],0.9995759620548411,0,0,1
267,Disruption of postsynaptic signaling by CNV WP4875,0.8431216004774484,0.5435201026518391,0.09274849009539188,['STX1A'],0.9995759620548411,0,0,1
268,DNA Replication WP466,0.8431216004774484,0.5435201026518391,0.09274849009539188,['PRIM1'],0.9995759620548411,0,0,1
269,Eukaryotic Transcription Initiation WP405,0.8431216004774484,0.5435201026518391,0.09274849009539188,['POLR2J'],0.9995759620548411,0,0,1
270,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8431216004774484,0.5435201026518391,0.09274849009539188,['NFKB1'],0.9995759620548411,0,0,1
271,miRNA regulation of prostate cancer signaling pathways WP3981,0.8431216004774484,0.5435201026518391,0.09274849009539188,['NFKB1'],0.9995759620548411,0,0,1
272,PI3K-Akt signaling pathway WP4172,0.8441836376688252,0.7418478260869565,0.12565806307178165,"['PPP2CA', 'IFNAR2', 'G6PC3', 'PPP2R2B', 'INSR', 'GNB2', 'PPP2R5B', 'NFKB1', 'ATF4']",0.9995759620548411,0,0,9
273,Integrin-mediated Cell Adhesion WP185,0.8527076248185271,0.5848229731288203,0.09318484530722436,"['MAPK6', 'MAP2K5']",0.9995759620548411,0,0,2
274,Adipogenesis WP236,0.8590730885276765,0.6160214268322376,0.09357444017584235,"['RBL1', 'DDIT3', 'MEF2D']",0.9995759620548411,0,0,3
275,NRF2 pathway WP2884,0.8590730885276765,0.6160214268322376,0.09357444017584235,"['SLC6A8', 'GPX3', 'SLC39A7']",0.9995759620548411,0,0,3
276,Type 2 papillary renal cell carcinoma WP4241,0.8613707017815733,0.5071856287425149,0.07568747330513317,['SETD2'],0.9995759620548411,0,0,1
277,Cytosolic DNA-sensing pathway WP4655,0.8613707017815733,0.5071856287425149,0.07568747330513317,['NFKB1'],0.9995759620548411,0,0,1
278,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8613707017815733,0.5071856287425149,0.07568747330513317,['NFKB1'],0.9995759620548411,0,0,1
279,Apoptosis WP254,0.8662022507543446,0.5630518074296186,0.08087498900912547,"['CRADD', 'NFKB1']",0.9995759620548411,0,0,2
280,Exercise-induced Circadian Regulation WP410,0.8662022507543446,0.5630518074296186,0.08087498900912547,"['ERC2', 'TOB1']",0.9995759620548411,0,0,2
281,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8688882299158694,0.6327067669172932,0.08892110328557448,"['MAZ', 'TPPP', 'SSTR2', 'NFKB1']",0.9995759620548411,0,0,4
282,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8774997274298013,0.47539296407185627,0.06212370328337468,['NFKB1'],0.9995759620548411,0,0,1
283,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8774997274298013,0.47539296407185627,0.06212370328337468,['FAF1'],0.9995759620548411,0,0,1
284,Ferroptosis WP4313,0.8774997274298013,0.47539296407185627,0.06212370328337468,['ATG7'],0.9995759620548411,0,0,1
285,IL-1 signaling pathway WP195,0.8774997274298013,0.47539296407185627,0.06212370328337468,['NFKB1'],0.9995759620548411,0,0,1
286,Interleukin-11 Signaling Pathway WP2332,0.8774997274298013,0.47539296407185627,0.06212370328337468,['ATF1'],0.9995759620548411,0,0,1
287,Notch Signaling Pathway Netpath WP61,0.8774997274298013,0.47539296407185627,0.06212370328337468,['NFKB1'],0.9995759620548411,0,0,1
288,Pathways affected in adenoid cystic carcinoma WP3651,0.8774997274298013,0.47539296407185627,0.06212370328337468,['SETD2'],0.9995759620548411,0,0,1
289,Peptide GPCRs WP24,0.8774997274298013,0.47539296407185627,0.06212370328337468,['SSTR2'],0.9995759620548411,0,0,1
290,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8774997274298013,0.47539296407185627,0.06212370328337468,['SYNPO'],0.9995759620548411,0,0,1
291,Wnt signaling WP428,0.8785538672407628,0.5428357249946455,0.07028531436877458,"['CTBP2', 'CXXC4']",0.9995759620548411,0,0,2
292,7q11.23 copy number variation syndrome WP4932,0.880735469425099,0.5841995841995842,0.07419215534035181,"['STX1A', 'ACACA', 'ATF4']",0.9995759620548411,0,0,3
293,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8898455863511343,0.5240138551413949,0.06115625780673918,"['MAP2K5', 'NFKB1']",0.9995759620548411,0,0,2
294,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8917546491428444,0.44734061289186333,0.05124923789715865,['PRKAB2'],0.9995759620548411,0,0,1
295,MET in type 1 papillary renal cell carcinoma WP4205,0.8917546491428444,0.44734061289186333,0.05124923789715865,['CRKL'],0.9995759620548411,0,0,1
296,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8917546491428444,0.44734061289186333,0.05124923789715865,['NFKB1'],0.9995759620548411,0,0,1
297,PDGF Pathway WP2526,0.8917546491428444,0.44734061289186333,0.05124923789715865,['NFKB1'],0.9995759620548411,0,0,1
298,VEGFA-VEGFR2 Signaling Pathway WP3888,0.8922403632870076,0.7411404928944054,0.084504629355676,"['IGFBP3', 'FAF1', 'TRIP4', 'NFKB1', 'ACACA', 'RND1', 'PPP2CA', 'LDHA', 'ARMCX1', 'FSCN1', 'ABL1', 'DNAJB9', 'IER5', 'SLC25A11', 'ATF4']",0.9995759620548411,0,0,15
299,ErbB signaling pathway WP673,0.9001566516469592,0.5064467766116941,0.05327135040597388,"['ABL1', 'CRKL']",0.9995759620548411,0,0,2
300,Aryl Hydrocarbon Receptor Netpath WP2586,0.9043529387365964,0.42240518962075846,0.04246674897091988,['NFKB1'],0.9995759620548411,0,0,1
301,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9043529387365964,0.42240518962075846,0.04246674897091988,['NFKB1'],0.9995759620548411,0,0,1
302,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9043529387365964,0.42240518962075846,0.04246674897091988,['SYNE1'],0.9995759620548411,0,0,1
303,Nucleotide Excision Repair WP4753,0.9043529387365964,0.42240518962075846,0.04246674897091988,['RAD23A'],0.9995759620548411,0,0,1
304,Fragile X Syndrome  WP4549,0.9076889929938972,0.5421492921492922,0.05250904442223435,"['AGAP2', 'PPP2R5B', 'GPHN']",0.9995759620548411,0,0,3
305,"GPCRs, Class A Rhodopsin-like WP455",0.9153672648889971,0.5294364131573434,0.04681801534390134,"['GPR27', 'GPR83', 'SSTR2']",0.9995759620548411,0,0,3
306,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9154868660197476,0.400094547746612,0.03532805297928852,['NFKB1'],0.9995759620548411,0,0,1
307,Circadian rhythm related genes WP3594,0.9174383783251998,0.5617376775271512,0.0484048592184761,"['KCNMA1', 'FBXL3', 'LGR4', 'ATF4']",0.9995759620548411,0,0,4
308,Insulin Signaling WP481,0.9174383783251998,0.5617376775271512,0.0484048592184761,"['INSR', 'FLOT1', 'MAPK6', 'MAP2K5']",0.9995759620548411,0,0,4
309,Nonalcoholic fatty liver disease WP4396,0.9210671030103552,0.6059728506787331,0.049824533949489054,"['PRKAB2', 'DDIT3', 'INSR', 'NDUFA2', 'NFKB1', 'ATF4']",0.9995759620548411,0,0,6
310,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9253264154749394,0.3800149700598802,0.029492476214052002,['MAP2K5'],0.9995759620548411,0,0,1
311,Complement system WP2806,0.9253264154749394,0.3800149700598802,0.029492476214052002,['C2'],0.9995759620548411,0,0,1
312,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9253264154749394,0.3800149700598802,0.029492476214052002,['NFKB1'],0.9995759620548411,0,0,1
313,Phosphodiesterases in neuronal function WP4222,0.9253264154749394,0.3800149700598802,0.029492476214052002,['PDE3B'],0.9995759620548411,0,0,1
314,Pancreatic adenocarcinoma pathway WP4263,0.9259363745001519,0.46013356957884693,0.03540716624683143,"['NFKB1', 'ARHGEF6']",0.9995759620548411,0,0,2
315,ESC Pluripotency Pathways WP3931,0.9330341485821135,0.44651203809859774,0.030949302314439053,"['MAPK6', 'MAP2K5']",0.9995759620548411,0,0,2
316,Mitochondrial CIV Assembly WP4922,0.9340218657410974,0.3618477331052181,0.024698072678997908,['CMC1'],0.9995759620548411,0,0,1
317,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9340218657410974,0.3618477331052181,0.024698072678997908,['NFKB1'],0.9995759620548411,0,0,1
318,Proximal tubule transport WP4917,0.9417060711266757,0.3453320631464344,0.02074136183092623,['SLC13A3'],0.9995759620548411,0,0,1
319,Regulation of Actin Cytoskeleton WP51,0.9457126856461681,0.47381756756756754,0.026446824530207764,"['SSH2', 'MAPK6', 'ARHGEF6']",0.9995759620548411,0,0,3
320,G1 to S cell cycle control WP45,0.9484964792137245,0.33025253840145796,0.01746283004065459,['PRIM1'],0.9995759620548411,0,0,1
321,Head and Neck Squamous Cell Carcinoma WP4674,0.9484964792137245,0.33025253840145796,0.01746283004065459,['NFKB1'],0.9995759620548411,0,0,1
322,Oncostatin M Signaling Pathway WP2374,0.9484964792137245,0.33025253840145796,0.01746283004065459,['NFKB1'],0.9995759620548411,0,0,1
323,Pyrimidine metabolism WP4022,0.9506587065001331,0.41006523765144454,0.020749366388668183,"['PRIM1', 'POLR2J']",0.9995759620548411,0,0,2
324,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9544969151038176,0.3164296407185629,0.014736402956874938,['PPP2CA'],0.9995759620548411,0,0,1
325,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9544969151038176,0.3164296407185629,0.014736402956874938,['ITPR2'],0.9995759620548411,0,0,1
326,DNA Repair Pathways Full Network WP4946,0.963802485875421,0.37908545727136433,0.01397646212304204,"['RAD23A', 'PALB2']",0.9995759620548411,0,0,2
327,Acute viral myocarditis WP4298,0.9644843434404053,0.2919737448180562,0.010558261009674464,['ABL1'],0.9995759620548411,0,0,1
328,Gastrin signaling pathway WP4659,0.9673823351743317,0.3697663363440231,0.01226199854768534,"['MEF2D', 'NFKB1']",0.9995759620548411,0,0,2
329,Glioblastoma signaling pathways WP2261,0.9686241837855333,0.2811044577511643,0.008961211380790606,['MAP2K5'],0.9995759620548411,0,0,1
330,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9722820725909886,0.2710115483319076,0.007617949924403833,['EXOC2'],0.9995759620548411,0,0,1
331,G Protein Signaling Pathways WP35,0.9722820725909886,0.2710115483319076,0.007617949924403833,['GNB2'],0.9995759620548411,0,0,1
332,Thermogenesis WP4321,0.975514043112335,0.2616147016312203,0.006485617656569666,['PRKAB2'],0.9995759620548411,0,0,1
333,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9831216266959408,0.23694797904191617,0.004033431898879758,['NDUFA2'],0.9995759620548411,0,0,1
334,Osteoblast differentiation WP4787,0.9850909388593623,0.22972237343494828,0.003450732904984363,['MAPK6'],0.9995759620548411,0,0,1
335,Hepatitis B infection WP4666,0.9874373952622814,0.30266866566716644,0.0038263921813020086,"['NFKB1', 'ATF4']",0.9995759620548411,0,0,2
336,Small cell lung cancer WP4658,0.9883677602653006,0.2165098374679213,0.002533256791238743,['NFKB1'],0.9995759620548411,0,0,1
337,TGF-beta Signaling Pathway WP366,0.9883677602653006,0.2165098374679213,0.002533256791238743,['RBL1'],0.9995759620548411,0,0,1
338,IL-18 signaling pathway WP4754,0.9894639420225431,0.41892570281124497,0.004437242279358507,"['STOML1', 'IMP3', 'LRRFIP1', 'RND2', 'NFKB1']",0.9995759620548411,0,0,5
339,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.991984699530031,0.19929877087929404,0.0016038759269733883,['MEF2D'],0.9995759620548411,0,0,1
340,Nuclear Receptors Meta-Pathway WP2882,0.9920128769256661,0.3724867724867725,0.0029870425771480135,"['PSMC5', 'SLC6A8', 'GPX3', 'SLC39A7']",0.9995759620548411,0,0,4
341,Oxidative phosphorylation WP623,0.9937475307892152,0.18925898203592814,0.001187050836737583,['NDUFA2'],0.9995759620548411,0,0,1
342,Focal Adhesion WP306,0.9992438129263448,0.13236684525685471,0.00010013196138443312,['CRKL'],0.9997193644057024,0,0,1
343,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9997193644057024,0.1158912943344081,3.252778670033958e-05,['NDUFA2'],0.9997193644057024,0,0,1
